Results

Total Results: 560 records

Showing results for "breast".
Users also searched for: breast cancer

301. Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
     April 01, 2010 - to identify patients diagnosed in 2006 with one of the following tumor types and stage IV disease: breast … At JHH/SKCCC, the cancer registry identified patients with stage IV lung, pancreatic, breast, and colorectal … Not all common malignancies were well-represented in this study (e.g., breast cancer), and further evaluation … African American Other 155 (65%) 76 (32%) 7 ( 2%) 73 (62%) 36 (30%) 9 (8%) Cancer Type Breast

302. COPD is common and respiratory failure due to COPD is an increasingly common disorder. Use of non-invasive positive pressure ventilation (NPPV) for patients with respiratory failure due to exacerbatons of COPD. Several trials and… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/copd-is-common-and-respiratory-failure-due-to-copd-is-an-increasingly-common-disorder-use-of-non-invasive-positive-pressure-ventilation-nppv-for-patients-with-respiratory-failure-due-to-exacerbatons-of-copd-several-trials-an
     November 01, 2017 - (You can also specify a particular health-promoting activity, such as breast-feeding) Respiratory failure

303. Thrombosis plays a a key role in the pathophysiology of myocardial infarction-a leading cause of morbidity and mortality. There have been a number of devices proposed for mechanical thrombectomy in patients with in the setting of acute… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/thrombosis-plays-a-a-key-role-in-the-pathophysiology-of-myocardial-infarction-a-leading-cause-of-morbidity-and-mortality-there-have-been-a-number-of-devices-proposed-for-mechanical-thrombectomy-in-patients-with-in-the-settin
     November 01, 2017 - (You can also specify a particular health-promoting activity, such as breast-feeding) Coronary artery

304. Middle Ear Infections: What to Expect and Treatment Options (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/ebc-challenge-3rdplace_tympanic.pdf
     January 26, 2013 - Bottle-fed vs. breast-fed 2. Passive cigarette smoking exposure 3.

305. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/health-literacy_research-protocol.pdf
     January 22, 2010 - Predictors of pessimistic breast cancer risk perceptions in a primary care population. … Black-white differences in risk perceptions of breast cancer survival and screening mammography benefit … Latina patient perspectives about informed treatment decision making for breast cancer. … Retention and use of breast cancer recurrence risk information from genomic tests: the role of health … Agreement between scales in the measurement of breast cancer risk perceptions.

306. Technical Brief 13: Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
     December 01, 2012 - In 2012, it is expected to be the fourth most commonly diagnosed cancer (after prostate, breast, and … cancer and aid in determination of prognosis in breast cancer.”6 Using GEP tests could improve the … Given the current role of GEP testing in patients with breast cancer, questions formulated in a report … for the AHRQ on GEP testing in patients with breast cancer11 were used to inform this Technical Brief … A breast cancer prognostic signature predicts clinical outcomes in multiple tumor types.

307. CER 218 Evidence Summary: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
     April 01, 2019 - In addition, estrogen/progestin was associated with an increased risk of invasive breast cancer. … harms varied by a long list of patient characteristics.44-47 Though results suggested that risk of breast … Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results … Breast Cancer Res Treat. 2001 Jan;65(2):125-34. PMID: 11261828. 29. … Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women

308. Disposition of Comments for Evidence Report 224 Omega-3 Fatty Acids (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
     October 12, 2016 - We acknowledge that not all trials included a breast fed group for benchmarking and that we did not … Again, we acknowledge that not all trials included a breast fed group for benchmarking and that we … Note: Breast-feeding Danish women were evaluated for the impact of supplementation during the first … In children with a FADS genotype linked to a low endogenous LC-PUFA synthesis, breast- feeding supplying … Therefore, it is recommended that women who are pregnant or breast-feeding consume at least 8 and up

309. Stakeholder Involvement in Improving Comparative Effectiveness Reviews: AHRQ and the Effective Health Care Program (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stakeholder-engagement_research.pdf
     September 01, 2011 - outcomes tables, such as those included below from the review of Medications to Reduce Risk of Primary Breast … Placebo Invasive breast cancer No difference 7 (4,12) † +++ 9 (4, 14) +++ 10 (3, 17) ++ Estrogen … Comparative Effectiveness of Medications to Reduce Risk of Primary Breast Cancer in Women.

310. Organisation (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-radiation_appendixes.pdf
     June 16, 2008 - Clinical Cancer Research 2004;10(5):1764-72. 15014030 Breast Bush DA, Slater JD, Garberoglio C, … A technique of partial breast irradiation utilizing proton beam radiotherapy: comparison with conformal … Accelerated partial-breast irradiation using proton beams: initial clinical experience. … Neutron versus photon radiotherapy for local control in inoperable breast cancer. … Accelerated partial breast irradiation using proton beams: Initial dosimetric experience.

311. Newly Medicare-Eligible Elders: Data Points #12 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medicare-utilization-seniors_research.pdf
     June 01, 2012 - heart disease.6 Cancer is indicated if one or more of the following cancers are classified: female breast … Part B, fee for service coverage, survived six months. ** Dual / Nondual monthly status changes. † Breast … Part B, fee for service coverage, survived six months. ** Dual / Nondual monthly status changes. † Breast

312. Methods Guide for Medical Test Reviews Chapter 7 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-grading_methods.pdf
     July 01, 2012 - of the use of non-invasive imaging in addition to standard workup after recall for evaluation of a breast … Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes. … Comparative Effectiveness of Core-Needle and Open Surgical Biopsy for the Diagnosis of Breast Lesions … Noninvasive Diagnostic Tests for Breast Abnormalities: Update of a 2006 Review.

313. Omega-3-Maternity Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/omega-3-maternity_research-protocol.pdf
     May 18, 2015 - from fish and other marine sources, some were from dietary supplements, some were indirect (through breast … is the influence of maternal intakes of n-3 fatty acids or the n-3 fatty acid content of maternal breast … -3 FA) or n-3 FA-supplemented infant formula or intakes of n-3 FA from sources other than maternal breast … fatty acids was assessed during pregnancy § Children whose exposure to n-3 fatty acids (through breast … n-3 fatty acids from foods if concentrations are quantified in food frequency questionnaires § Breast

314. Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
     February 01, 2017 - 26, all histologies 89Sr with dendritic cell vaccine 40 0 NR NR 58% at 36 mo Yamada, 201214 16, breast … Concurrent use of Sr-89 chloride with zoledronic acid is safe and effective for breast cancer patients … Bone-related complications and quality of life in advanced breast cancer: Results from a randomized phase … versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast … Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast

315. Medical Care Journal Supplement (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/toc.pdf
     January 01, 2007 - Effect Estimates from Risk-Adjustment and Instrumental Variable Methods: Surgery for Early- Stage Breast

316. Blood-based Tests for Multiple Cancer Screening: A Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-draft-report.pdf
     December 01, 2024 - Results from two systematic reviews limited to evaluating lung, colorectal, breast, ovarian, and prostate … Data from 41 RCTs were included from trials for lung (n=12), colorectal (n=11), breast (n=6), ovarian … The correlation estimates for breast and prostate cancer could not exclude a null correlation at either … Cancer Type Number of Studies Correlation, Earliest Followup Correlation, Last Followup Breast … Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement.

317. Methods-Balancing-Harms-Benefits Research-2012 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research-2012.pdf
     January 01, 2012 - A well-known example is the use of tamoxifen for the prevention of breast cancer. … They then estimated, for each outcome and based on the Breast Cancer Prevention Trial, the expected … Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. … Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast … The International Breast Cancer Study Group. Cancer Treat Rev. 1993; 19 Suppl A:73-84. 58.

318. Research White Paper Managing Missing Data in Patient Registries Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/missing-data-registries-guide-3rd-ed-addendum-white-paper.pdf
     February 01, 2018 - death (by any cause besides heart attack) prevents incident heart attack from occurring; in a study of breast … cancer, preventive double mastectomy likewise may be considered a competing risk for breast cancer. … risks can lead to missing data in certain settings; sometimes a study may be interested in the risk of breast … beliefs about their personal risks 3 Managing Missing Data in Patient Registries of developing breast … In such a setting, the breast cancer status that these women would have had, had they not gotten a mastectomy

319. Measuring Healthcare Organization Characteristics in Cancer Care Delivery Research | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/organization-cancer-care/tech-brief
     October 01, 2023 - Few studies examined diagnostics or diagnostic outcomes, such as breast cancer diagnosis quality measures

320. What is the comparative effectiveness of various local treatments for (1) unresectable liver metastases and (2) unresectable, localized hepatocellular carcinoma (HCC)? Does the comparative effectiveness vary when lesions are unresectable… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-of-various-local-treatments-for-1-unresectable-liver-metastases-and-2-unresectable-localized-hepatocellular-carcinoma-hcc-does-the-comparative-effectiveness-vary-when-lesions-are-unresec
     November 01, 2017 - It may also occur with other common tumors such as breast cancer.